ATRA
Atara Biotherapeutics Inc
Halal Rating :
Last Price
$6.70
Last updated:
Market Cap
-
7D Change
-58.62%
1 Year Change
1014.62%
Company Overview
Industries
Exchange
Next Earnings Date
Atara Biotherapeutics is a biotechnology company focused on developing innovative T-cell immunotherapy treatments for patients with cancer, autoimmune, and viral diseases. The company's primary focus is on developing allogeneic T-cell therapies using their proprietary Expanded T-cell (EBV T-cell) platform technology.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $40.19m | $63.13m | - | $1.18m | 0.00% | 1.87% |
| June 30, 2024 | $28.64m | $48.13m | - | $1.26m | 0.00% | 2.62% |
| March 31, 2024 | $27.36m | $59.76m | - | $1.15m | 0.00% | 1.93% |
Company Impact
Help us evaluate Atara Biotherapeutics Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.